ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-11.14%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$286M
AUM Growth
+$286M
(-6.2%)
Cap. Flow
+$17.2M
Cap. Flow
% of AUM
6.02%
Top 10 Holdings %
Top 10 Hldgs %
53.89%
Holding
37
New
6
Increased
5
Reduced
8
Closed
5
Top Buys
| 1 |
ISO
IsoPlexis Corporation Common Stock
ISO
|
$16.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
$10.8M |
| 3 |
Guardant Health
GH
|
$10.5M |
| 4 |
Lantheus
LNTH
|
$9.53M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$5.02M |
Top Sells
| 1 |
Gossamer Bio
GOSS
|
$7.92M |
| 2 |
Viridian Therapeutics
VRDN
|
$5.93M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$5.68M |
| 4 |
MacroGenics
MGNX
|
$5.38M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$4.84M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stoke Therapeutics
STOK
$1.08B
| $4.44M | 1.55% |
+185,000
| New | +$4.44M |
|
|
MDVL
27
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $4.09M | 1.43% |
2,920,780
| – | – |
|
|
VERV
28
DELISTED
Verve Therapeutics
VERV
| $4.07M | 1.42% |
110,360
+95,360
| +636% | +$3.52M |
|
|
CYT
29
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $3.63M | 1.27% |
319,538
| – | – |
|
|
30
MacroGenics
MGNX
$121M
| $482K | 0.17% |
30,000
-335,000
| -92% | -$5.38M |
|
31
Adicet Bio
ACET
$60.8M
| – | – |
-425,000
| Closed | -$3.33M |
|
32
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
0
| – | – |
|
33
Bolt Biotherapeutics
BOLT
$9.29M
| – | – |
-257,267
| Closed | -$3.25M |
|
34
SPDR NYSE Technology ETF
XNTK
$1.24B
| – | – |
0
| – | – |
|
|
NVTA
35
DELISTED
Invitae Corporation
NVTA
| – | – |
-199,900
| Closed | -$5.68M |
|
|
CELL
36
DELISTED
PhenomeX Inc. Common Stock
CELL
| – | – |
-201,996
| Closed | -$3.95M |
|
|
AMRS
37
DELISTED
Amyris Inc.
AMRS
| – | – |
-352,445
| Closed | -$4.84M |
|